Trial Profile
A study evaluating efficacy and safety of ledipasvir/sofosbuvir in Japanese hemophilia patients with genotype 1 or 4 hepatitis C infection
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Jan 2017
Price :
$35
*
At a glance
- Drugs Ledipasvir/sofosbuvir (Primary)
- Indications Haemophilia; Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- 04 Jan 2017 New trial record
- 07 Dec 2016 Results published in the JAIDS